# Towards Optimal Treatment for High Risk Prostate Cancer

> **NCT06204341** · NA · RECRUITING · sponsor: **Haaglanden Medical Centre** · enrollment: 207 (estimated)

## Conditions studied

- High Risk Prostate Carcinoma

## Interventions

- **RADIATION:** HYPOPRIME treatment

## Key facts

- **NCT ID:** NCT06204341
- **Lead sponsor:** Haaglanden Medical Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-02
- **Primary completion:** 2032-12-18
- **Final completion:** 2032-12-18
- **Target enrollment:** 207 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06204341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06204341, "Towards Optimal Treatment for High Risk Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06204341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*